China Spacesat Co.,Ltd. Stock

Equities

600118

CNE000000SM3

Aerospace & Defense

End-of-day quote Shanghai S.E. 18:00:00 2024-06-12 EDT 5-day change 1st Jan Change
23.79 CNY -0.83% Intraday chart for China Spacesat Co.,Ltd. -1.04% -7.86%

Financials

Sales 2024 * 8.16B 1.12B 1.55B Sales 2025 * 9.39B 1.29B 1.78B Capitalization 28.13B 3.88B 5.33B
Net income 2024 * 201M 27.71M 38.12M Net income 2025 * 247M 34.05M 46.84M EV / Sales 2024 * 3.45 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 3 x
P/E ratio 2024 *
140 x
P/E ratio 2025 *
113 x
Employees 3,419
Yield 2024 *
0.17%
Yield 2025 *
0.17%
Free-Float 47.29%
More Fundamentals * Assessed data
Dynamic Chart
China Spacesat Swings to Q1 Loss as Operating Income Plunges 75% MT
China Spacesat Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
China Spacesat's 2023 Profit Falls 45%, Operating Income Declines 17% MT
China Spacesat Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Spacesat Co.,Ltd.(SHSE:600118) added to Shanghai Stock Exchange 180 Value Index CI
China Spacesat Co.,Ltd.(SHSE:600118) added to SSE 180 Index CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China Spacesat Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
China Resources Double-Crane Pharmaceutical Co.,Ltd. acquired 50.1% stake in Shenzhou Biology & Technology Co., Ltd from Aerospace Shenzhou Biology & Technology Group Co., Ltd , China Aerospace Investment Holdings Ltd , China Spacesat Co.,Ltd. and Beijing Dawn Aerospace Bio-tech Co., Ltd. CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire 50.1% stake in Shenzhou Biology & Technology Co., Ltd. for approximately CNY 500 million. CI
China Spacesat Co.,Ltd.(SHSE:600118) dropped from SSE 180 Index CI
More news
1 day-0.83%
1 week-1.04%
Current month-5.48%
1 month-4.73%
3 months-8.99%
6 months-8.46%
Current year-7.86%
More quotes
1 week
23.75
Extreme 23.75
24.33
1 month
23.70
Extreme 23.7
25.40
Current year
20.37
Extreme 20.37
26.85
1 year
20.37
Extreme 20.37
31.97
3 years
16.38
Extreme 16.38
34.78
5 years
16.38
Extreme 16.38
45.97
10 years
14.83
Extreme 14.83
81.90
More quotes
Managers TitleAgeSince
Director of Finance/CFO 45 21-11-04
President 46 21-06-28
Corporate Officer/Principal 54 17-05-17
Members of the board TitleAgeSince
Director/Board Member 55 21-06-28
Director/Board Member 61 09-08-09
Director/Board Member 57 21-06-28
More insiders
Date Price Change Volume
24-06-13 23.79 -0.83% 7,079,262
24-06-12 23.99 -0.66% 8,191,620
24-06-11 24.15 +0.33% 6,574,947
24-06-07 24.07 +0.12% 8,474,480
24-06-06 24.04 -2.95% 12,568,110

End-of-day quote Shanghai S.E., June 12, 2024

More quotes
China Spacesat Co Ltd is a China-based company principally engaged in aerospace manufacturing and satellite applications. The aerospace manufacturing business mainly includes satellite system development and aerospace component manufacturing. The satellite application business mainly includes satellite application technology equipment manufacturing and satellite application services. The Company mainly operates its businesses in China, with North, Northwest and South China as its main market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
23.79
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600118 Stock